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Neuronal activity controls Bdnf expression via
Polycomb de-repression and CREB/CBP/JMJD3
activation in mature neurons
Ernest Palomer1, Javier Carretero1, Stefano Benvegnu`1, Carlos G. Dotti1 & Mauricio G. Martin1,2
It has been recently described that in embryonic stem cells, the expression of some important
developmentally regulated genes is repressed, but poised for fast activation under the
appropriate stimuli. In this work we show that Bdnf promoters are repressed by Polycomb
Complex 2 in mature hippocampal neurons, and basal expression is guaranteed by
the coexistence with activating histone marks. Neuronal stimulation triggered by
N-methyl-D-aspartate application induces the transcription of these promoters by H3K27Me3
demethylation and H3K27Me3 phosphorylation at Serine 28 leading to displacement of
EZH2, the catalytic subunit of Polycomb Repressor Complex 2. Our data show that the fast
transient expression of Bdnf promoters II and VI after neuronal stimulation is dependent on
acetylation of histone H3K27 by CREB-p/CBP. Thus, regulatory mechanisms established
during development seem to remain after differentiation controlling genes induced by
different stimuli, as would be the case of early memory genes in mature neurons.
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A
ctivity-regulated gene transcription is involved in multiple
biological processes, among others, in neuronal survival1,2
and in the late phases of long-term potentiation (LTP)
and long-term depression (LTD), the processes underlying
memory formation3,4. One of the most extensively studied
genes that are regulated by neuronal activity is the brain-
derived neurotrophic factor (BDNF) which plays important roles
in neuronal differentiation, survival and synaptic plasticity1,5.
Bdnf transcription is upregulated by membrane depolarization
in vitro1,6 and during induction of LTP or associative learning
in vivo7–10. Neuronal activity is also an important regulator for
the temporal and spatial expression of different Bdnf
isoforms11–14.
The Bdnf gene is unusual in that it contains multiple promoters
that are speciﬁcally regulated under different conditions to
generate mRNAs containing different 50 noncoding exons each of
which can be alternatively spliced in a tissue- and stimulus-
speciﬁc manner to two alternative 30 exons containing the coding
sequence15–17. This gene architecture is highly conserved in
mammals. In rat and mouse, eight Bdnf exons with separate
promoters have been characterized18–20.
Recent works indicates that synaptic activity regulates Bdnf
expression through epigenetic control of its promoter regions. For
example, contextual fear conditioning in mice results in increased
H3 acetylation at the Bdnf promoter IV (ref. 21) and defeat stress
induces the downregulation of Bdnf transcripts IV and VI
accompanied by increased H3K27 dimethylation at these
promoters22. The intimate mechanisms by which different
cognition-associated stimuli regulate the activity of speciﬁc Bdnf
promoters are not yet known.
Polycomb repressive complexes (PRC) are required to silence
an important subset of developmental regulator genes in both
human and mouse embryonic stem (ES) cells, to ensure that
expression occurs only at later stages upon ES cell differentia-
tion23,24. Genome-wide25 and candidate-based chromatin
studies26 indicate that the transcriptional start sites of some of
these genes are frequently present in a bivalent state: that is, the
presence of histone modiﬁcations associated with gene activation
(trimethylated H3K4) and with PRC2-mediated gene repression
(trimethylated H3K27). A characteristic observed for these
promoters in ES cells is that the presence of H3K4Me3 shows a
strong positive correlation with the presence of CpG islands in
the underlying DNA sequence, whereas the presence of H3K27-
trimethylated regions showed also a strikingly low density of
transposon-derived sequences (transposon exclusion zones or
TEZs)25. Interestingly, CpG islands are present at the Bdnf
promoters of exons I, II, IV and VI and also a transposon
exclusion zone was found overlapping these four transcriptional
start sites promoters25.
We here show that activator and repressor epigenetic marks
coexist at Bdnf promoters I, II, IV and VI in mature hippocampal
neurons and LTD leads to PRC2 derepression of these promoters.
The transcriptional proﬁle of these promoters presents two
different responses to the stimulus: a slower and stable
transcriptional activation of promoters I and IV and the fast
transient induction of promoters II and VI. Although the four
Bdnf promoters share the same regulatory mechanism mediated
by polycomb, the fast expression of promoters II and VI also
requires H3K27 acetylation. Our data present a novel mechanism
involved in the transcriptional regulation of Bdnf in mature
neurons.
Results
Transcriptional analysis of Bdnf promoters. We ﬁrst deter-
mined if low doses of N-methyl-D-aspartate (NMDA), a stimulus
known to lead to LTD27–30, is able to induce expression
changes of Bdnf promoters. Hippocampal neurons mainta-
ined in culture for 2 weeks were exposed during 5min
to 20 mM NMDA and the expression levels of exons I, II, IV
and VI were determined by quantitative PCR (qPCR) at
different time-points after stimulation. Figure 1a,b shows
that a signiﬁcant increase was observed for transcripts
II and VI at 10min after NMDA addition. The amount of
these mRNAs reached a peak at 30min after stimulation
and returned to basal levels at later time-points: 60min
for mRNA VI and 180min for mRNA II. The expression of
exons I and IV, however, presented a different behaviour
since a signiﬁcant increase of these mRNAs was observed
only after 30min upon stimulation. The levels of mRNA I
remained at maximum along the entire length of time
analysed (180min), while the levels of mRNA IV returned
to basal at 180min after NMDA application.
These results reveal that chemically induced LTD (NMDA-
LTD) triggers two different responses of these Bdnf promoters, a
fast response of promoters II and VI driving a transient
expression of Bdnf exons II and VI and a slower response of
promoters I and IV, leading to a more stable expression of exons I
and IV.
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Figure 1 | Response of Bdnf promoters to NMDA stimulation in mature
hippocampal neurons. (a) Real-time qPCR analysis of the levels of Bdnf
mRNAs transcribed from promoters I, II, IV and VI after NMDA stimulation
(8–14 independent experiments). (b) The bar plot shows the relative
amount of each transcript compared with non-stimulated controls at 10 or
30min after NMDA addition. Data are represented as mean±s.e.m.
Statistical analysis by Kruskal–Wallis test and subsequent multiples
comparisons by Mann–Whitney U-test with Bonferroni adjustment
(n: independent experiments or biological replicates; *Po0.05; **Po0.01,
***Po0.001; for statistical analysis see Supplementary Table 1).
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Epigenetic marks found at Bdnf promoters in mature neurons.
As commented in the Introduction, the structure and genetic
environment of Bdnf promoters I, II, IV and VI suggest that they
are potential sites to be controlled by repressive (PRC) and
activating (H3K4Me3) marks. Hence, we next assessed if activator
trimethyl-H3K4 (H3K4Me3) and repressor trimethyl-H3K27
(H3K27Me3) are present at Bdnf promoters under non-
stimulated conditions. In addition, we also searched for
the presence of acetyl-H3K27 (H3K27Ac) as an activation form
of the H3K27 mark. Chromatin immunoprecipitation (ChIP)
assays followed by promoter-speciﬁc qPCR performed in
non-stimulated hippocampal neurons revealed that these
three histone marks are present in all the four Bdnf promoters
(Fig. 2a–c).
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Figure 2 | NMDA stimulation induces epigenetic remodelling of Bdnf promoters. (a–e) ChIP-qPCR analysis of epigenetic marks and regulatory proteins
bound at Bdnf promoters in basal conditions: (a) H3K27Ac, (b) H3K4Me3, (c) H3K27Me3, (d) EZH2 and (e) JMJD3. The plots also show the levels of the
respective marks found at the promoter region of two control genes: a constitutively transcribed bActin and a repressed gene hoxA1. (f) ChIP-qPCR analysis
showing the changes in the levels of these proteins at the Bdnf promoters measured 10min after NMDA stimulation. The phosphorylation of H3K27Me3 at
Serine 28, which is reported to displace the repressor EZH2, is also analysed. (g) ChIP-qPCR analysis shows that the levels of these proteins do not change
10min after NMDA stimulation at control bActin and hoxA1 promoters. Data are represented as mean±s.e.m. Statistical analysis by Mann–Whitney U-test
(the value inside the bars corresponds to n, number of cultures used in independent experiments; *Po0.05; **Po0.01, ***Po0.001; for statistical analysis
see Supplementary Table 2).
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11081 ARTICLE
NATURE COMMUNICATIONS | 7:11081 | DOI: 10.1038/ncomms11081 | www.nature.com/naturecommunications 3
The amount of each histone mark at Bdnf promoters was
compared with the amount bound to the promoters of two
control genes, bActin and hoxA1. In fact, the constitutively active
b-Actin presents high levels of activator marks H3K27Ac and
H3K4Me3 (Fig. 2a,b) and low levels of the repressive H3K27Me3
mark (Fig. 2c). In contraposition, the constitutively repressed
hoxA1 showed high levels of the repressive H3K27Me3, low
amounts of H3K4Me3 and undetectable H3K27Ac (Fig. 2a–c).
To further substantiate that Bdnf promoters I, II, IV and VI are
repressed by PRC in non-stimulated neurons, we determined the
level of association to Enhancer of zeste homologue 2 (EZH2), the
catalytic subunit of the PRC2, to these promoters. ChIP
experiments revealed the presence of EZH2 associated to the
four Bdnf promoters (Fig. 2d) at levels that are comparable to the
levels bound to the PRC2 repressed gene hoxA1. Strikingly, a
similar ChIP experiment revealed that, different from hoxA1,
high levels of the H3K27Me3-demethylase Jumonji domain
containing-3 (JMJD3) were present at these Bdnf promoters
suggesting that these promoters are ready to be de-repressed by
H3K27Me3 demethylation (Fig. 2e).
NMDA leads to epigenetic remodelling at Bdnf promoters. To
test if NMDA-LTD induces quantitative changes in the different
histone marks at our target promoters, similar ChIP experiments
were performed in 2-week-old hippocampal neurons in culture
10min after NMDA stimulation. Figure 2f shows the result of this
study: the activation marks H3K4Me3 and H3K27Ac, as well as
the JMJD3 demethylase, all increased by the LTD stimulus at
promoters II and VI. Furthermore, NMDA treatment resulted in
lower levels of the repressor EZH2 at promoters II and VI and
reduction of the repressive H3K27Me3 mark at promoter VI.
These results may explain the enhanced expression of these
transcripts after NMDA stimulation. On the other hand, no
change in the levels of these marks were detected at promoter I
after stimulation, according to the later expression time of this
transcript (30min, see Fig. 1a). However, in promoter IV, which
also undergoes a delayed increased expression (see Fig. 1a),
signiﬁcant decreased levels of repressor EZH2 were accompanied
by recruitment of the H3K27Me3-demethylase JMJD3 and
decreased amount of H3K27Me3, which would imply de-
repression at this early time. However, different from promoters
II and VI, no increase of the activator marks H3K4Me3 and
H3K27Ac was observed at this promoter implying that both,
increase of activation marks and decreased repressive marks, are
required for fast transcriptional induction.
Changes were not observed in the levels of these epigenetic
marks at the promoter regions of the control genes bActin and
hoxA1, which are not regulated by NMDA (Fig. 2g).
ChIP experiments performed 30min after NMDA stimulation
showed that the levels of all histone marks and their upstream
regulators were restored to basal conditions. Signiﬁcantly, lower
levels of H3K27Ac, compared with non-stimulated controls, were
observed at promoters II, IV and VI (Supplementary Fig. 1A),
suggesting that H3K27Ac deacetylation is involved in the
silencing of these promoters after stimulus. However, the
possibility of a general effect triggered after NMDA-LTD could
not be discarded since reduced levels of H3K27Ac were also
observed at the control genes 30min after NMDA application
(Supplementary Fig. 1B).
Derepression of Bdnf requires H3K27Me3S28 phosphorylation.
It has been reported that p38 MAPK and mainly its downstream
kinases, mitogen- and stress-activated kinases (Msk1 and Msk2),
lead to gene activation through H3K27Me3 phosphorylation at
Serine 28, the consequent displacement of the SUZ12 subunit of
PRC2 and promoter derepression31. That was proposed as a
mechanism required to activate a subset of Polycomb group of
proteins (PcG) target genes by stress-signalling in diploid human
ﬁbroblasts and after differentiation signals in human embryonic
teratocarcinoma cells31. ChIP experiments revealed that
H3K27Me3S28 phosphorylation occurs at Bdnf promoters II and
VI after 10min of NMDA stimulation (Fig. 2f), suggesting that a
similar mechanism may participate during NMDA-induced Bdnf
expression in mature neurons. In the Supplementary Fig. 2A we
show that the antibody used in our experiments presents a weak
cross-reaction with H3K9Me3S10p, much less than previously
reported for other rabbit polyclonal antibodies for H3K27Me3S28p
(refs 31,32).
To assess if the p38 MAPK pathway may be involved in
H3K27Me3S28 phosphorylation in mature neurons, we treated
NMDA-stimulated hippocampal neurons with the p38-speciﬁc
inhibitor SB-203580 (refs 33–35).The qPCR analysis revealed that
this treatment prevented NMDA-induced increase of transcripts
II and VI (Fig. 3a). Moreover, ChIP experiments showed that p38
MAPK inhibition abolished NMDA-induced H3K27Me3S28
phosphorylation at promoters II and VI (Fig. 3b). According to
these results, ChIP assays performed using a ChIP-validated
antibody against p38 (Supplementary Fig. 2B) showed that LTD-
induced recruitment of p38 to promoters II and VI at 10min after
stimulation (Supplementary Fig. 2C,D).
In further support that phosphorylation of H3K27Me3S28 is
required for Polycomb removal, p38 inhibition precluded EZH2
displacement from Bdnf promoters II and VI after NMDA
stimulation (Fig. 3c). The expression of exons I and IV was not
affected by the treatment with the inhibitor (Fig. 3a,b), further
strengthening our early assumption that promoters I and IV are
controlled by different mechanisms. Although the SB-203580 also
blocked the release of EZH2 from promoters I and IV (change
not signiﬁcant for promoter I), increases in H3K27Me3S28p were
not observed in these two promoters after NMDA stimulation,
further strengthening the notion that both de-repression and
activation are required for NMDA-induced Bdnf expression.
Altogether, these data show that the p38 pathway is involved in
H3K27Me3S28 phosphorylation and required for the displace-
ment of EZH2 from promoters II and VI after NMDA treatment.
Gehani et al.31 have demonstrated that Msk1/2 kinases are
required for H3K27Me3S28 phosphorylation in human
ﬁbroblasts. Furthermore, by in vitro experiments these authors
have shown that Msk2 kinase phosphorylates H3K27Me3S28
more efﬁciently than p38. Hence, it appears reasonable to
conclude that p38 could lead to H3K27Me3S28 phosphorylation
by a dual, direct and indirect (via its downstream kinases Msk2
and Msk1) mechanism. Moreover, the results presented here also
suggest that the EZH2 displacement could be involved, but is not
sufﬁcient, to induce the de-repression of promoters I and IV.
JMJD3 recruitment to Bdnf is required for activation by LTD.
Our ChIP experiments showed that JMJD3 demethylase is
recruited to promoters II, IV and VI after LTD induction
(Fig. 2f). To test if JMJD3 demethylase activity is in fact playing a
role for the transcriptional induction of these Bdnf promoters,
ChIP and qPCR were performed in hippocampal neurons treated
with the Jumonji H3K27Me3-demethylase inhibitor GSK-J4
(ref. 36) at the time of stimulation. The qPCR experiment
revealed that GSK-J4 inhibited the transcriptional activation of
promoters II and VI but had no effect on promoters I and IV
(Fig. 3d). The ChIP experiments conﬁrmed that GSK-J4 treat-
ment impaired the decrease of H3K27Me3 observed after NMDA
on promoters IV and VI (Fig. 3e). The absence of changes in the
levels of H3K27Me3 at promoter II at 10min after stimulation
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Figure 3 | LTD-induced transcription of Bdnf promoters II and VI requires EZH2 displacement and H3K27Me3 demethylation and acetylation. (a) Real-
time qPCR analysis of the Bdnf transcripts shows that treatment with the p38 inhibitor SB-203580 blocks the increase of mRNAs transcribed from
promoters II and VI at 30min after NMDA stimulation. (b,c) ChIP-qPCR analysis performed 10min after stimulation shows that SB-203580 impairs
H3K27Me3S28 phosphorylation at promoters II and VI (b). Interestingly, SB-203580 blocked EZH2 displacement from the four promoters studied
suggesting a role for EZH2 in the transcriptional control of these regions (c). (d) The real-time qPCR analysis show that the H3K27Me3-demethylases
inhibitor GSK-J4 impairs the NMDA-triggered increase of Bdnf mRNAs II and VI observed 30min after stimulation. (e) ChIP-qPCR studies conﬁrm that
H3K27Me3 demethylation observed at Bdnf promoters IV and VI is blocked by GSK-J4. (f) Real-time qPCR showing that the increased expression of Bdnf
mRNAs II and VI observed 30min after NMDA stimulation is impaired when CREB-CBP interaction is blocked by CCIIh. (g–k) ChIP-qPCR analysis show
that treatment with CCIIh: blocked H3K27 acetylation at promoters II and VI (g), it does not block CREB binding to Bdnf promoters (h), it prevents CBP
recruitment to promoters I, II, IV and VI (i) it prevents JMJD3 recruitment at promoters II, IV and VI (j) and H3K27Me3 demethylation at promoters IV and
VI (k). Data are represented as mean±s.e.m. Statistical analysis by Kruskal–Wallis test and subsequent multiples comparisons by Mann–Whitney U-test
with Bonferroni adjustment (the value inside the bars corresponds to n, number of cultures used in independent experiments; *Po0.05; **Po0.01,
***Po0.001; for statistical analysis see Supplementary Table 3).
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suggests either that H3K27Me3 demethylation at this promoter
occurs at a lower extent than at promoter VI or that it is not
detected at 10min after stimulation. Again, the increase of
mRNAs containing exons I and IV was unaffected by the treat-
ment, further supporting the notion that these promoters are
controlled by a different regulatory mechanisms. As a matter of
fact, even if the GSK-J4 prevented H3K27Me3 demethylation at
promoter IV (Fig. 3e), it did not block its activation (Fig. 3d).
The GSK-J4 inhibitor is able to block the catalytic activity of
the KDM6 demethylase proteins but also blocks the activity of
demethylases from the KDM2, KDM3, KDM4 and KDM5
subfamilies37. KDM3 and KDM4 proteins demethylate the
repressor mark H3K9Me3, meaning that inhibition of these
proteins by GSK-J4 could block induction of the Bdnf promoters
after LTD; however, by ChIP experiments we found that no
H3K9Me3 demethylation is observed at any of the four Bdnf
promoters at 10min after NMDA application (Supplementary
Fig. 3A).
In agreement with the pharmacological results, the qPCR
analysis show that JMJD3 knockdown blocked the NMDA-
mediated Bdnf induction of transcripts II and VI (Supplementary
Fig. 3B–E). H3K27Me3 demetylation was also blocked by JMJD3
knockdown (Supplementary Fig. 3F). All together, these results
conﬁrm that JMJD3 is involved in H3K27Me3 demethylation
after NMDA-LTD.
It has been described that H3K27Me3 phosphorylation at
Serine 28 masks the recognition of H3K27Me3 by different
speciﬁc antibodies31,32, an event also observed by us (see
Supplementary Fig. 4A). It means that the decreases observed
in the levels of H3K27Me3 at Bdnf promoters after stimula-
tion could be attributed to epitope masking rather than true
demethylation. However, experiments based on extracts obtained
from neuronal cultures treated with alkaline phosphatase to
remove the phosphate group from H3K27Me3S28p (see
Supplementary Fig. 4B), followed by ChIP with H3K27Me3
antibodies, still revealed demethylation. These ChIPs show a
signiﬁcant decrease of H3K27Me3 at promoters IV and VI in
phosphatase-treated samples indicating that H3K27Me3
demethylation does occur in an epitope unmasked situation
(Supplementary Fig. 4C). In vitro assays using the human
recombinant catalytic domain of JMJD3, suggest that JMJD3 is
able to demethylate the phosphorylated peptide H3K27Me3S28p
(Supplementary Fig. 5A–C). If this is the case in vivo, in this
three-way scenario where H3K27Me3S28 phosphorylation,
H3K27Me3 demethylation and H3K27Me3S28p demethylation
occur, it becomes very difﬁcult to assess the magnitude of the
contribution of epitope masking to the H3K27Me3 decrease. In
any case, our observations indicate that epitope masking would
not be the major determinant of decreased H3K27Me3 levels
under LTD because: (i) H3K27Me3 demethylation is prevented
by inhibiting demethylase activity with GSK-J4 or by JMJD3
knockdown (Fig. 3e and Supplementary Fig. 3F); (ii) H3K27Me3
demethylation is prevented by inhibiting JMJD3 recruitment to
chromatin (Fig. 3j,k); (iii) H3K27Me3 demethylation is still
observed after LTD in samples treated with Alkaline Phosphatase,
that is, in the absence of epitope masking (Supplementary
Fig. 4C); and (iv) there is not a direct correlation between
H3K27Me3S28 phosphorylation and H3K27Me3 decrease (see
Bdnf promoters II and IV in Fig. 2f and Bdnf promoter I in
Fig. 4g).
Bdnf induction requires CREB-p/CBP/ JMJD3. Several signal-
ling pathways lead to the activation of cyclic AMP response
element-binding protein (CREB) kinases, which phosphorylate
CREB on the residue Ser133 (refs 38–40). Upon phosphorylation at
Ser133, CREB translocates to the nucleus and recruits the
transcriptional co-activator CREB-binding protein (CBP) with
histone acetyl transferase activity41. We speculated that a similar
mechanism could explain the H3K27 acetylation
induced by NMDA stimulation (see Fig. 2f). Consistent with
this possibility, NMDA-LTD triggers a transient CREB
phosphorylation at Serine 133 (CREB-pS133) 10min after
stimulation (Supplementary Fig. 6A). To determine the pathway
by which NMDA stimulation, that is, Ca2þ /calmodulin-
dependent protein kinase II (CamKII) or protein kinase C
(PKC), leads to CREB phopsphorylation, hippocampal neurons
were treated with the CamKII inhibitor KN93 or the PKC inhibitor
Chelerytrine before NMDA stimulation. The levels of pS133-CREB
were then determined by western blot at 10min after LTD
induction. Either KN93 or chelerythrine were able to block
CREB phosphorylation at 10min after NMDA stimulation
(Supplementary Fig. 6B and C), suggesting that NMDA-LTD
may require synergic activities between PKC and CamKII, like
previously reported during LTP. In fact, it was shown that PKC
potentiates NMDA receptor gating, in turn enhancing Ca2þ inﬂux
and intracellular Ca2þ /camodulin, which could trigger CaMKII
autophosphorylation42–44. To further dissect the pathway leading
to S133-CREB phosphorylation, we analysed the contribution of
MSK1, a downstream kinase common to PKC and CamKII
pathways. Hippocampal neurons were incubated with the MSK1
inhibitor H89 before NMDA stimulation. As shown in
Supplementary Figure 6D, the treatment with H89-blocked
CREB phosphorylation at 10min after NMDA stimulation
indicating that MSK1 triggers CREB phosphorylation at Ser 133.
We can conclude that NMDA- LTD leads to S133-CREB
phosphorylation via CamKII-PKC/MSK1 kinases. However, since
H89 also inhibits PKA with a similar potency45, we could not
exclude a role of PKA in the phosphorylation of CREB by NMDA.
Coherent with the CREB activation, NMDA triggers a transient
and a signiﬁcant increase in the acetylation of H3K27 at 10min
after treatment (Supplementary Fig. 6E). Such increased acetylation
of H3 was not observed at other lysine residues, H3K9, H3K14 or
H3K18, after NMDA addition (Supplementary Fig. 6F–H). To
directly assess the functional association between H3K27 acetyla-
tion and CREB activation, we treated hippocampal neurons
with CREB-pS133/CBP interaction inhibitor (CCIIh) to impair
CREB-pS133/CBP binding46,47. This treatment blocked the
transcriptional activation of promoters II and VI and impaired
H3K27 acetylation at these promoters (Fig. 3f,g). These results
conﬁrm that CREB-p/CBP is required for H3K27 acetylation and
activation of promoters II and VI by NMDA-LTD. No changes of
H3K27Ac were observed at promoters I and IV at 10min after
induction and in fact, the activation of these promoters was
unaffected by the inhibitor (Fig. 3f,g). Active CREB was found at
the Bdnf promoters either in the presence or absence of the
inhibitor in NMDA-stimulated neurons (Fig. 3h). However,
treatment with the CREB/CBP inhibitor CCIIh blocked the
recruitment of CBP (Fig. 3i).
The CCIIh inhibitor blocks the interaction between the KID
domain of CREB and the KIX domain of CBP. This KIX domain in
CBP also interacts with the p65 subunit of the transcriptional
activator nuclear factor kB (NFkB), implying that the interaction
CBP-p65 is also disrupted by CCIIh (ref. 46). Although a role of
NFkB has been described in the activation of Bdnf promoters I and
IV but not in the activation of promoters II and VI (refs 48–50),
the possibility exists that the observed effect of CCIIh could be due
to inhibition of the recruitment of CBP by NFkB to promoters II
and VI.
Zhong et al.51 have shown that the activation of p65 by
phosphorylation at its serine 276 is strictly required for the
interaction with CBP: in Supplementary Fig. 7, we show that
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application of 20 mM NMDA to hippocampal neurons in culture
was not able to trigger phosphorylation of p65Ser273 at 10min
after stimulation, indicating that p65 is not involved in the
recruitment of CBP to Bdnf promoters at least at this time point
after NMDA stimulation.
The interaction of CBP with the demethylase UTX from the
lysine-speciﬁc demethylase 6 (KDM6) family has been
described52, opening the possibility that CREB-p/CBP complex
would be also involved in the recruitment of the demethylase
JMJD3 (also a member of the KDM6 family) to the Bdnf
promoters after stimulation. By ChIP experiments we conﬁrmed
that the recruitment of JMJD3 to promoters II, IV and VI is
impaired by CCIIh (Fig. 3j). In addition, CCIIh blocked the
H3K27Me3 demethylation induced by NMDA at promoters IV
and VI (Fig. 3k). Note that CCIIh treatment also resulted in
signiﬁcantly higher levels of H3K27Me3 at promoter II after
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Figure 4 | Experiments performed in acute hippocampal slices validate the results in vitro. (a) According to the data in vitro, real-time qPCR analysis
performed in acute hippocampal slices from adult mice show that NMDA stimulation triggers the increase of the BdnfmRNAs transcribed from promoters I,
II, IV and VI at 30min after stimulation. The data represent the mRNA levels relative to unstimulated controls. (b–f) ChIP-qPCR analysis performed in acute
hippocampal slices from adult mice. The presence of activator and repressor histone marks and the Polycomb protein EZH2 indicate that Bdnf promoters I,
II, IV and VI are bivalent in adult mice: (b) H3K27Me3, (c) EZH2, (d) JMJD3, (e) H3K4Me3 and (f) H3K27Ac. The levels of these proteins at promoter
regions of the control genes bActin and hoxA1 are also shown in the plots. (g) ChIP-qPCR analyses show that NMDA stimulation leads to H3K27Me3S28
phosphorylation and displacement of the polycomb protein EZH2, JMJD3 demethylase recruitment, H3K27Me3 demethylation and increased levels of the
activator H3K4Me3 at the four Bdnf promoters I, II, IV and VI. H3K27 acetylation was observed only at promoters II and VI suggesting that this mark is
responsible for the fast induction of these two promoters. (h) ChIP-qPCR analyses at promoter regions of the control genes bActin and hoxA1 after NMDA
stimulation. The data show that, except for the increased levels of JMJD3 observed at the bActin promoter, none of the other marks present changes after
NMDA stimulation. Data are represented as mean±s.e.m. Statistical analysis by Mann–Whitney U-test (the value inside the bars indicates the number of
animals used in independent experiments; *Po0.05; **Po0.01, ***Po0.001; for statistical analysis see Supplementary Table 4).
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stimulation (Fig. 3k). These results support our previous
conclusion that H3K27Me3 demethylation is required for
induction of promoter II (Fig. 3d), but it occurs at lower levels
than at promoters IV and VI. The direct interaction CBP-JMJD3
was further conﬁrmed by co-immunoprecipitation
(Supplementary Fig. 8).
From these results we conclude that the mechanism of Bdnf
induction triggered by NMDA involves CREB-p-mediated
recruitment of CBP and JMJD3 to all Bdnf promoters, yet rapid
transcription from promoters II and VI requires H3K27Me3
demethylation followed by H3K27 acetylation.
Validation in acute hippocampal slices. Our results indicate that
Bdnf promoters II and VI are subjected to EZH2 repression and
that, after speciﬁc neuronal stimuli, the increased transcriptional
activity is due to the release of the repressor EZH2 as a
consequence of H3K27Me3Ser28 phosphorylation, H3K27Me3
demethylation and H3K27 acetylation. Because our data were
obtained in neurons grown in vitro, we decided to test our model
in neurons that had developed and matured in a physiological
environment. Thus, we analysed the effect of NMDA-LTD on the
expression and epigenetic remodelling at Bdnf promoters in
hippocampal slices prepared from adult mice. Similar to what
occurs in vitro, NMDA addition to hippocampal slices resulted in
increased levels of mRNA species II and VI at 10min, and in
increased levels of the four species at 30min after stimulation
(Fig. 4a). Likewise in vitro, higher increases were observed for
mRNAs transcribed from promoters II and VI (Fig. 4a). Also
paralleling the data in cultures, the repressive H3K27Me3 and
EZH2 marks were detected at these four Bdnf promoters in non-
NMDA-stimulated slices (Fig. 4b,c). High amounts of JMJD3
demethylase were also found at these promoters (Fig. 4d), sug-
gesting that transcriptional activity requires H3K27Me3 deme-
thylation. As expected, the presence of activation marks
H3K4Me3 and H3K27Ac were also observed at promoters I, II,
IV and VI at the same proportions than in neuronal cultures
(Fig. 4e,f). However in hippocampal slices, the amount of
H3K27Ac found at promoter II was comparable to the levels
found at the repressed gene hoxA1, suggesting a low basal tran-
scriptional activity for this promoter.
The ChIP experiments performed in hippocampal slices
revealed that LTD induces phosphorylation of H3K27Me3S28p
and displacement of EZH2 not only at promoters II and VI
but also at promoters I and IV (Fig. 4g). These results streng-
then the conclusion previously obtained from in vitro data
that phosphorylation of H3K27Me3S28 displaces EZH2 repre-
ssor from all the four promoters (see Fig. 3c). In hippo-
campal slices, H3K27Me3 demethylation was also evident at
promoter II (Fig. 4g), explaining the effect of GSK-J4 on this
promoter in vitro (see Fig. 3d). Interestingly, increases of the
activation mark H3K4Me3 was observed for all the four
promoters in hippocampal slices (Fig. 4g). Similar to in vitro
grown hippocampal neurons, H3K27 acetylation in hippocampal
slices was only evident at promoters II and VI (Fig. 4g),
suggesting that H3K27 acetylation may be the relevant modulator
for the fast induction of these two promoters after stimulation.
Except for an increase in JMJD3 interaction with bActin
promoter, for which we do not have an explanation, no other
changes in the levels of these marks were observed at the
promoters of the control genes (Fig. 4h).
All in all, the results obtained in hippocampal slices
reinforce the notion that these four promoters of Bdnf are
controlled by PRC2 repressor and suggest that fast (10min)
response of promoters II and VI would be due to H3K27
acetylation.
Discussion
In this work, we show that neuronal stimulation with low doses of
NMDA, a protocol widely used to induce LTD, triggers the fast
transient activation of Bdnf promoters II and VI, whereas
promoters I and IV present a slower response with a transcrip-
tional activation remaining stable for longer time.
The biological signiﬁcance of this alternative promoter usage
could be explained from the works developed by Baj et al.14 These
authors have shown that the transcripts containing the 50exons II
and VI are transported to distal dendrites whereas the transcripts
containing 50exons I and IV are required in the soma or in
proximal dendrites. By use of overexpression and silencing of
speciﬁc Bdnf mRNA isoforms, the authors found that dendritic
BDNF (from exons II and VI) plays a role in secondary dendrites’
plasticity in response to external stimuli. Furthermore, the
expression of individual Bdnf splice variants was shown to be
relevant for the spatially restricted activation of TrkB receptors:
that is, overexpression of exons I or IV transcripts led to
phosphorylation of 80–100% of TrkB receptors within the ﬁrst
45 mm from the soma, whereas overexpressing exons II or VI
Bdnf variants led to 80% TrkB phosphorylation at 80 mm from the
soma and beyond. Thus, the spatial segregation of Bdnf
transcripts enables this neurotrophic factor to differentially
shape distinct dendritic compartments.
At ﬁrst sight it would seem that a fast induction of a promoter
localized more than 50 kb 50 away from the Bdnf coding exon
(exon IX) is not, physiologically speaking, the optimal situation.
However the fast induction of promoter II in our model would
have an important biological signiﬁcance. Because the ultimate
destination of Bdnf mRNAs is dictated by the presence of
different 50-untranslated region exons, it means that the fast
induction of promoters II and VI at 10min after LTD induction
would be required to provide the stimulated cell with the
adequate amounts of 50exons II and VI-containing transcripts at
the appropriate timing to be delivered to distal dendrites.
We have shown that, in adult non-stimulated neurons, Bdnf
promoters are present in a partially repressed status exerted by
EZH2. Application of NMDA at doses that produce chemical
LTD leads to the remodelling of the transcriptional complexes,
namely increased levels of activator H3K4Me3 and recruitment of
H3K27Me3-demethylase JMJD3 and by the consequent decrease
of the repressive mark H3K27Me3. We also found that LTD
stimulus triggers the phosphorylation of the H3K27Me3 at its Ser
28 leading to the displacement of the repressor protein EZH2
(Fig. 5). In proof of functional association between these changes
and activation of Bdnf expression, preventing H3K27Me3S28
phosphorylation blocks EZH2 release and the transcriptional
stimulation of promoters II and VI.
It has been demonstrated that retinoic acid induce neural
differentiation in human embryonic teratocarcinoma cells via
histone H3K27Me3S28 phosphorylation, displacement of poly-
comb proteins and gene expression31. Our data suggest that a
similar mechanism may operate in fully mature neurons in vitro,
in response to a memory-related stimulus. Although
H3K27Me3S28 phosphorylation, EZH2 derepression and
H3K27Me3 demethylation also occur after LTD at Bdnf
promoters I and IV, blocking these processes does not impair
the late occurring transcriptional induction of these two
promoters, suggesting that polycomb derepression is mostly
restricted to promoters II and VI.
The molecular mechanism by which a physiological mnemonic
process like LTD affects Bdnf expression has not been studied
previously. However, it has been shown that methyl-CpG-binding
protein 2 (MeCP2) represses promoter IV through the association
with the co-repressor molecule Sin3a and histone deacetylase 1
(HDAC1)53–56. Membrane depolarization by KCl correlated with
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DNA demethylation and MeCP2 phosphorylation and
dissociation from Bdnf promoter IV (refs 53,55). NMDA
receptor activation de-represses Bdnf promoters I and IV in
correlation with reduced occupancy by HDAC1 and MeCP2 in
cultured hippocampal neurons49,57. Since memory consolidation
after fear conditioning involves LTD induction, it is possible that
DNA demethylation and MeCP2 derepression would be also
involved in the activation of promoters I and IV after LTD.
The chromodomain protein and transcription co-repressor
chromodomain Y-like (CDYL) protein represses Bdnf promoter
II in developing neurons by a polycomb-mediated mechanism.
De-repression can be induced by electrical activity through the
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degradation of CDYL58. We analysed whether a
CDYL-dependent mechanism would also contribute to the
expression changes of any of the Bdnf transcripts triggered by
NMDA.
While CDYL was enriched at Bdnf promoter II this was not the
case for promoters I, IV and VI (Supplementary Fig. 9A).
The levels of CDYL bound to promoter II decreased signiﬁca-
ntly and remained low at 30min after NMDA stimula-
tion (Supplementary Fig. 9B) in coincidence with protein
degradation induced by the stimulus (Supplementary Fig. 9C).
However the basal levels of EZH2 are restored at promoter II,
30min after induction (Supplementary Fig. 1A). These data
indicate ﬁrst, that CDYL would not be involved in the de-
repression of Bdnf promoter VI and second, that CDYL would
not be involved in EZH2 recruitment to promoter II at 30min
after stimulation. However it cannot be excluded that CDYL
degradation would be required also in mature neurons together
with H3K27Me3S28 phosphorylation for EZH2 displacement
from promoter II.
The regulation of neuronal differentiation by members of the
polycomb group of proteins has been widely described. In adult
mice, a role for EZH2 in the regulation of adult neurogenesis has
also been reported and impaired learning and memory was
attributed to the decreased proliferation of the progenitor cells in
Ezh2 knockout mice59. We here show that EZH2 directly controls
memory formation by regulating the expression of Bdnf gene in
mature neurons.
LTD induction increases the levels of the activator mark
H3K27Ac only at promoters II and VI, suggesting that H3K27
acetylation is an important factor in the high transient mRNA
expression mediated by these two promoters (Fig. 5). It is well
known that neuronal stimulation by NMDA activates a signalling
cascade resulting in CREB phosphorylation60,61. Phosphorylated
CREB moves to the nucleus and interacts with the histone acetyl
transferase CBP. The presence of a CREB-binding site has been
previously observed at promoter IV and a possible role for CREB
in the regulation of this promoter has been proposed but not
directly demonstrated55,62. Our results demonstrate that H3K27
acetylation is catalysed by the CREB-p/CBP complex, as
inhibition of the CREB-p/CBP interaction impairs H3K27
acetylation and transcriptional activation of promoters II and
VI. We also show that this mechanism is not involved in the
activation of promoters I and IV.
Our results strengthen the notion that synaptic activity
differentially controls the Bdnf promoters by use of epigene-
tic mechanisms that include H3K27 acetylation via CREB/CBP
and polycomb de-repression in mature neurons. It is tempting to
speculate that a similar epigenetic mechanism may regulate
the expression of other early genes involved in learning and
memory.
Methods
Primary hippocampal neurons. Primary cultures of hippocampal neurons were
prepared from embryonic day 18 (E18) Wistar rats as described in Kaech and
Banker63 For our experiments hippocampal neurons were kept in culture for 15
days in vitro (15 DIV), when they have reached full maturation.
Hippocampi were dissected and placed into ice-cold Hank’s solution with 7mM
HEPES and 0.45% glucose. The tissue was then treated with 0.005% trypsin
(trypsin 0.05% EDTA; (Invitrogen; Life Technologies Co.) and incubated at 37 C
for 16min and then treated with DNase (72 mgml 1; Sigma-Aldrich) for 1min at
37 C. Hippocampi were washed three times with Hank’s solution. Cells were
dissociated in 5ml of plating medium (Minimum Essential Medium supplemented
with 10% horse serum and 20% glucose) and cells were counted in a Neubauer
Chamber. Cells were plated into dishes pre-coated with poly-D-lysine (Sigma-
Aldrich) (750,000 cells in a 10 cm dish and 270,000 in a 6 cm dish) and placed into
a humidiﬁed incubator containing 95% air and 5% CO2. The plating medium was
replaced with equilibrated neurobasal media supplemented with B27 and
GlutaMAX (Gibco; Life Technologies Co.). On DIV 7 the culture medium was
replaced with medium without GlutaMAX. Cultures were used 15 DIV.
Hippocampal Slices. Hippocampal slices were prepared from 7–9-months-old
male C57BL/J mouse. Hippocampi were extracted in dissection solution (10mM
D-glucose, 4mM KCl, 26mM NaHCO3, 233.7mM sucrose, 5mM MgCl2 and
1:1,000 Phenol Red) and sliced in an automatic tissue chopper (McIlwain Tissue
Chopper, Standard Table, 220V, Ted Pella Inc.) to obtain 400 mm hippocampal
slices. Then, slices were kept in artiﬁcial cerebrospinal ﬂuid (119mM NaCl, 2.5mM
KCl, 1mM NaH2PO4, 11mM glucose, 1.2mM MgCl2, 2.5mM CaCl2. Osmolarity
was adjusted to 290Osm) for 1 h. Finally the experiments were performed in
artiﬁcial cerebrospinal ﬂuid at 25 C.
Drug treatments. Stock solutions of CBP-CREB Interaction Inhibitor (250mM
(CCIIh); Millipore ref. 217505), KDM6A/B inhibitor (GSK-J4; 100mM; Tocris
Bioscience ref. 4594) and p-38 MAK inhibitor (SB203580; 100mM; Axon Med-
chem ref. Axon 1363) were prepared in dimethyl sulfoxide (Sigma). NMDA
(20mM; Sigma-Aldrich ref. M3262) was prepared in Milli-Q water. Hippocampal
neurons were treated with 5 mM CCIIh (1 h), 10mM GSK-J4 (1 h) or 10mM
SB203580 (1 h) before NMDA-LTD induction. LTD was induced by 20 mM NMDA
for 5min, and the medium was replaced. Samples were collected 5 or 25min after
LTD induction. Samples without LTD induction were used as a control.
Quantitative RT–PCR. Total RNA from hippocampal neurons or slices were
extracted with Trizol Reagent (Ambion/RNA Life Technologies Co.) following the
manufacturer procedures and cleaned up using RNeasy Mini kit (Qiagen, Hilden,
Germany). RNA was quantiﬁed by absorbance at 260 nm using a Nanodrop
ND-100 (Thermoscientiﬁc; Themo Fisher Scientiﬁc Inc.). Retrotranscription to
ﬁrst strand cDNA was performed using RevertAid H Minus First Strand cDNA
Synthesis kit (Thermoscientiﬁc; Themo Fisher Scientiﬁc Inc.). Brieﬂy, 5 ng of
synthesized cDNA was used to perform fast qPCR using GoTaq qPCR Master Mix
(Promega Co., Madison, WI, USA) in ABI PRISM 7900HT SDS (Applied Bio-
systems; Life Technologies Co.) with the manufacturer’s protocol. The primers
purchased to Sigma-Aldrich (Supplementary Table 13) were used at 0.5 mM ﬁnal
concentration to detect Bdnf transcripts and Jmjd3. Three housekeeping genes
Gapdh, GusB and Pgk1 were used as endogenous controls.
Chromatin immunoprecipitation. ChIP experiments were performed as described
by Millanes-Romero et al.64 Brieﬂy, 750,000 cells were crosslinked with 1%
formaldehyde for 10min at 37 C. Slices were crosslinked with 1% formaldehyde
for 15min at room temperature. Crosslinking was stopped by adding glycine to a
ﬁnal concentration of 0.125M for 2min at room temperature. Samples were
washed three times with cold PBS and homogenized in cold Soft Lysis Buffer
(50mM Tris (pH 8.0), 10mM EDTA, 0.1% NP-40 and 10% glycerol) plus
inhibitors (protease inhibitor (cOmplete, EDTA-free; Roche), phosphatase
inhibitor cocktail 2 (Sigma-Aldrich) and NaBut (5mM) (Sigma-Aldrich)). Finally,
lysates were centrifuged at 3,000 r.p.m. at 4 C for 15min. Nuclei pellets were lysed
with SDS Lysis Buffer (1% SDS, 10mM EDTA and 50mM Tris (pH 8.0)) plus
inhibitors and extracts were sonicated with Bioruptor Plus 300 to generate
400–700 bp DNA fragments. Samples were centrifuged at 13,000 r.p.m., 4 C,
10min to remove insoluble material, and the supernatant containing DNA–protein
complexes was collected. In addition, protein quantiﬁcation from sonicated
chromatin was performed using Pierce BCA protein assay kit (Thermoscientiﬁc;
Themo Fisher Scientiﬁc Inc.). The chromatin was diluted 1/10 with dilution buffer
(0,01% SDS, 1,1% Triton X-100, 1,2mM EDTA pH8, 16,7mM Tris pH 8 and
167mM NaCl) and pre-cleared with 50 ml protein A/G agarose beads (Santa Cruz
Biotechnology, Inc.) and 40 mg of normal IgG (Santa Cruz Biotechnology, Inc.) for
each 500 mg of protein. Samples were placed in a rotor for 1–3 h at 4 C. The
mixture was centrifuged and the supernatant was collected. A total of 100 mg of
protein were used for each ChIP assay, reserving 10 mg as the input. The antibodies
(Supplementary Table 14) were added to the chromatin lysate, incubated on a rotor
O/N at 4 C. Immune complexes were precipitated by the addition protein A/G
agarose beads. As a negative control, non-immune rabbit IgG (Santa Cruz
Biotechnology, Inc.) was used in place of speciﬁc antibodies. Immunoprecipitated
complexes were washed three times with the following buffers: Low-salt wash
buffer (0,1% SDS, 1% Triton X-100, 2mM EDTA pH8, 20mM Tris pH 8 and
150mM NaCl); high-salt wash buffer (0,1% SDS, 1% Triton X-100, 2mM EDTA
pH8, 20mM Tris pH 8 and 500mM NaCl); and LiCl wash buffer (250mM LiCl,
1% NP-40, 1% NaDOC, 1mM EDTA and 10mM Tris pH8). Immune complexes
were eluted in 100ml of 1% SDS and 100mM NaHCO3 at 37 C for 30min. DNA–
protein crosslinks were reversed by adding NaCl to a ﬁnal concentration of
200mM O/N at 60 C. Protein digestion was preformed 1 h at 37 C by adding
Proteinase K 0.04mgml 1 (Promega ref. MC5005), 50mM EDTA pH8 and
500mM Tris pH6,5 at ﬁnal concentration. Finally, DNA was puriﬁed with
QIAquick Gel Extraction Kit following the manufacturer procedures (Qiagen,
Hilden, Germany) and eluted in 140ml DNA/RNAse free MilliQ water. A total of
4 ml of puriﬁed DNA was used to perform a qPCR, using the listed primers on
Supplementary Table 13. In all the cases, the ChIPs for histone marks have been
normalized for general H3.
Statistical analysis. All values are presented as mean±s.e.m. Mann–Whitney
U-test and Kruskal–Wallis followed by Mann–Whitney U-test multiple
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comparisons with Bonferroni adjustment were used for statistical analysis of the
data using SPSS6 (SPSS6 Statistics, IBM). P values lower than 0.05 were considered
signiﬁcant.
The sample size was chosen by setting the values of type I error (a) and power
to the statistically adequate values of 0.05 and 0.80, respectively. Samples were
discarded when LTD did not increase the levels of Bdnf mRNAs at 30min after
induction.
In the ﬁgures asterisks indicate P values as follows: *o0.05; **o0.01; and
***o0.001. The exact P values are shown in the Supplementary Tables.
Because in the in vitro and ex vivo experiments, treatments were compared with
control conditions, there was no blinding in the experimental design. In all the
cases, the control and correspondent treated samples were processed
simultaneously and were obtained from the same culture or from slices prepared
from the same animal.
Animal handling. All the experiments were performed in accordance with Eur-
opean Union guidelines (2010/63/UE) regarding the use of laboratory animals.
Supplementary Information. For details and other protocols used in this work see
Supplementary Methods.
The entire blots corresponding to the Western blots shown in the
Supplementary Figures are presented in Supplementary Figure 10 and
Supplementary Figure 11.
The numeric data corresponding to the experiments shown in Supplementary
Figures 1 to Supplementary Figure 9 are presented in Supplementary Tables 5 to 12
as indicated in each Supplementary Figure Legend.
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